Hernia Repair Devices And Procedures Market Size and Share
Hernia Repair Devices And Procedures Market Analysis by Mordor Intelligence
The hernia repair devices and procedures market stands at USD 6.77 billion in 2025 and is forecast to climb to USD 8.37 billion by 2030, reflecting a 4.34% CAGR. Stable growth is taking shape as the field matures, yet continuous device innovation, wider ambulatory surgery center (ASC) use and robotic adoption keep procedural volumes and average selling prices on an upward slope. Demand also remains anchored to a sizeable clinical need: more than 6.75 million patients lived with hernia in 2021, and incidence is trending higher in aging, increasingly obese populations. Robotic inguinal repair penetration jumped from 0.8% to 24.2% in just six years, while ventral repairs moved from 0.02% to 17.0%, underscoring a decisive technological shift. Synthetic polypropylene mesh keeps its cost-driven lead, but biologic and biosynthetic alternatives are scaling quickly as centres seek lower chronic-pain and infection rates. Litigation headwinds have started to clear—BD’s USD 1 billion settlement in October 2024 removed a major overhang—enabling manufacturers to reinvest in next-generation materials, fixation technologies and surgical robotics.
Key Report Takeaways
- By product, synthetic polypropylene mesh led with 48.43% revenue share in 2024; biologic and biosynthetic mesh is projected to expand at a 6.34% CAGR through 2030.
- By procedure, open tension-free repair held 42.52% of the hernia repair devices and procedures market share in 2024, while robotic-assisted laparoscopic repair is pacing the field at a 6.66% CAGR to 2030.
- By hernia type, inguinal repairs captured 66.32% share in 2024; incisional and ventral repairs are the fastest-growing at 6.67% CAGR.
- By material, synthetic options accounted for 71.23% share in 2024; biologic materials are rising at a 7.01% CAGR.
- By end user, hospitals commanded 61.34% share in 2024, whereas ASCs are expanding at a 7.86% CAGR on cost and convenience advantages.
- By geography, North America maintained 40.34% share in 2024; Asia-Pacific is advancing at a 5.67% CAGR, lifted by infrastructure upgrades and rising surgical volumes.
________________________________________
Global Hernia Repair Devices And Procedures Market Trends and Insights
Driver Impact Analysis
Driver | % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
---|---|---|---|
Rising global surgical hernia burden | +1.2% | Worldwide; highest in aging markets | Long term (≥4years) |
Advancements in minimally invasive repair technologies | +0.8% | North America & Europe leading; Asia-Pacific scaling | Medium term (2-4years) |
Expanding insurance coverage for elective hernia surgeries | +0.6% | United States, Canada, Western Europe | Medium term (2-4years) |
Growing adoption of composite and lightweight meshes | +0.4% | Global; first in premium healthcare systems | Short term (≤2years) |
Surge in ambulatory surgery center procedures | +0.7% | United States; spreading to Europe | Medium term (2-4years) |
Integration of robotics and AI for enhanced surgical outcomes | +0.5% | High-income economies | Long term (≥4years) |
Source: Mordor Intelligence
Rising Global Surgical Hernia Burden
Worldwide hernia incidence is climbing, with analysts projecting a 19.7% increase in new cases by 2050 as populations age and obesity rates rise. Adults older than 45 now account for most new diagnoses, and a male-to-female ratio of roughly 7:1 concentrates demand among men. In low- and middle-income nations such as India and China, procedural backlogs persist, positioning these regions as sizeable untapped volumes once surgical capacity expands. The sheer epidemiologic weight supplies the hernia repair devices and procedures market with steady baseline growth.
Advancements In Minimally Invasive Repair Technologies
Robotic systems and improved laparoscopic instrumentation deliver smaller incisions, less postoperative pain and faster return to work. Real-world data showed median console times of 37 minutes for unilateral robotic repairs and quick learning curves among early adopters. Although capital expense remains high, payer coverage is broadening and AI-guided planning is expected to shorten training cycles. Premium mesh designs compatible with robotic delivery also command higher average selling prices, supporting revenue gains even where case volumes plateau.
Expanding Insurance Coverage For Elective Hernia Surgeries
Medicare introduced a cost measure specific to hernia repair in its 2024 Merit-based Incentive Payment System, covering more than 1 million annual procedures at average costs of USD 2,000-2,500. At the same time, 2023 CPT code revisions improved billing accuracy, and private insurers have started reimbursing robotic techniques when evidence shows fewer readmissions[1]American College of Surgeons, “2023 CPT Code Revisions for Hernia,” facs.org. Reimbursement stability incentivises surgeons to adopt premium technologies, feeding sustained equipment and mesh turnover.
Growing Adoption Of Composite And Lightweight Meshes
Poly-4-hydroxybutyrate, ePTFE-polypropylene hybrids and fully resorbable biosynthetics promise lower chronic pain and infection rates. BD’s Phasix mesh posts tensile strength three times greater than native tissue yet absorbs in 12-18 months. Gore’s SYNECOR provides 2.5x stronger repair and under 1% recurrence, underpinning price premiums. Surgeons treating obese or contaminated fields increasingly reserve conventional heavyweight polypropylene for cost-sensitive cases.
Restraints Impact Analysis
Restraints Impact Analysis | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
---|---|---|---|
High cost of biologic and biosynthetic meshes | -0.9% | Global; acute in price-sensitive markets | Medium term (2-4 years) |
Product recalls and litigation over mesh complications | -1.1% | North America & Europe | Short term (≤ 2 years) |
Shortage of skilled laparoscopic and robotic surgeons | -0.7% | Emerging and low-volume markets | Long term (≥ 4 years) |
Procurement delays due to capital budget constraints in hospitals | -0.4% | Public and rural hospitals worldwide | Short term (≤ 2 years) |
Source: Mordor Intelligence
High Cost Of Biologic And Biosynthetic Meshes
Biologic patches derived from porcine dermis or bovine pericardium can cost 5-10 times more than polypropylene, limiting uptake where payer budgets are tighter. Even biosynthetics such as Gore BIO-A run well above heavyweight mesh, and extended operating-room time adds further expense. Hospitals in emerging markets therefore default to suture-only or basic polypropylene techniques, tempering global adoption curves.
Product Recalls And Litigation Over Mesh Complications
More than 86,000 adverse-event reports filed since 2019 prompted the FDA to release draft labelling guidance in June 2025[2]U.S. FDA, “Draft Guidance for Hernia Surgical Mesh,” Federal Register, federalregister.gov. While BD’s USD 1 billion settlement resolved 38,000 lawsuits, pending cases against smaller suppliers create caution among surgeons and procurement teams, pushing some facilities back to established, lower-risk products. Compliance costs and longer trial timelines weigh on new-product ROI in the near term.
Segment Analysis
By Product: Synthetic Mesh Dominance Faces Biologic Challenge
Synthetic polypropylene commanded 48.43% of revenue in 2024, underscoring its entrenched clinical track record and budget-friendly pricing. The hernia repair devices and procedures market size for synthetic mesh equated to nearly half of total industry sales last year. Lightweight, large-pore designs are helping retain share by reducing postoperative pain. Biologic and biosynthetic alternatives hold smaller volume now but are climbing at 6.34% CAGR as infection-prone ventral cases drive surgeons toward absorbable or hybrid constructs.
The fixation sub-segment is modernising as well. TELA Bio’s LIQUIFIX, the first FDA-cleared liquid adhesive for internal hernia use, is gaining traction for its uniform distribution and reduced tack trauma. Antimicrobial coatings, especially chlorhexidine films, are also differentiating suppliers by cutting infection risk versus gentamicin-impregnated competitors[3]Frontiers Research Group, “Antimicrobial Mesh Coatings,” Frontiers in Cellular and Infection Microbiology, frontiersin.org. Suppliers that marry mesh, fixation and adjunct tools into single-vendor kits strengthen their stickiness with purchasing committees.
Note: Segment shares of all individual segments available upon report purchase
By Procedure: Robotic Revolution Accelerates Despite Open Surgery Persistence
Open tension-free Lichtenstein still represented 42.52% of 2024 procedures, a testament to surgeon familiarity and low consumable cost. For many straightforward inguinal cases, hospitals retain this approach to maximise throughput and minimise capital spend. Yet robotic-assisted laparoscopic repair is advancing at 6.66% CAGR, winning converts for complex bilateral and ventral presentations where ergonomics and 3-D visualisation pay off.
The hernia repair devices and procedures market share for robotic systems continues to rise as ASC investment grows and vendors roll out lower-priced four-arm models. Early recurrence spikes reported in Nordic registries appear tied to learning curves rather than intrinsic technique flaws. AI-enhanced vision is expected to flatten that curve, broadening the surgeon pool and lifting disposable instrument volumes.
By Hernia Type: Inguinal Dominance Masks Ventral Growth Opportunity
Inguinal repairs generated 66.32% of 2024 volume, supported by a clear male disease bias and well-defined outpatient pathways. The hernia repair devices and procedures market size allocated to inguinal repairs will hold steady through 2030 even as other categories outpace growth. Incisional and ventral repairs, at a 6.67% CAGR, are rising on the back of higher abdominal surgery rates, obesity and better imaging that uncovers complex fascial defects earlier.
Advanced meshes that resist infection and reinforce large gaps are specifically designed for ventral cases, allowing suppliers to charge up to 3-times inguinal-mesh ASPs. Innovative approaches—such as posterior rectus sheath flaps for paraesophageal augmentation—show how technique evolution underpins demand for specialised materials.
By Material: Synthetic Leadership Challenged by Biologic Innovation
Synthetic fibres controlled 71.23% share in 2024 due to their favourable price-to-performance ratio and widespread surgeon familiarity. Yet biologic and hybrid biosynthetic meshes, advancing at 7.01% CAGR, are gaining ground in contaminated fields and high-risk patients. The hernia repair devices and procedures market share advantage of synthetics will narrow slightly as reimbursement accommodates proven infection-sparing benefits of premium alternatives.
Gore BIO-A, for example, demonstrated 83% intact repairs in complex ventral cases while costing under half of traditional porcine-based dermal patches. At the same time, platelet-rich fibrin barriers are moving toward clinical use, potentially improving synthetic-mesh compatibility and extending the practical life of cheaper implants.

Note: Segment shares of all individual segments available upon report purchase
By End User: Hospital Dominance Faces ASC Disruption
Hospitals remained the primary customer base with 61.34% share in 2024, largely because complex or redo repairs often need multidisciplinary support and overnight observation. Nonetheless, ASCs are growing at 7.86% CAGR as reimbursement parity improves and protocols enable same-day discharge even for bilateral laparoscopic cases.
More than 3,000 U.S. ASCs now list hernia repair as a core service, and firms such as Medtronic offer bundled “ASC-fit” robotic packages with lower capital outlays and pay-per-use instrument pricing. Specialty hernia centres—often physician-owned—are emerging as referral hubs, intensifying purchasing power and demanding integrated device ecosystems.
Geography Analysis
North America generated 40.34% of global revenue in 2024, supported by high procedure volumes, early technology uptake and broad insurance coverage. Medicare alone reimburses more than 1 million hernia repairs annually, translating to a USD 2.5 billion addressable spend for meshes, fixation and instruments. U.S. robotic penetration in inguinal repair hit 24.2% by 2019, and the FDA’s new labelling guidance is expected to standardise performance claims, smoothing future rollouts. Canada and Mexico add incremental growth through cross-border medical tourism and infrastructure upgrades.
Europe trails slightly but benefits from robust clinical registries that favour premium devices with long-term data. Germany, the United Kingdom and France are early adopters of lightweight and biosynthetic meshes, while Southern Europe is raising laparoscopic and robotic volumes to cut LOS and chronic pain. The 2025 European launch of TELA Bio’s OviTex Inguinal underpins distributor interest in solutions optimised for minimally invasive and robotic delivery. Nonetheless, reimbursement heterogeneity across 27 EU states requires suppliers to tailor value dossiers country by country.
Asia-Pacific is the fastest-growing geography, advancing at 5.67% CAGR through 2030. China and India each conduct more than 1 million repairs yearly, yet mesh usage remains uneven, creating white-space for economical synthetics and mid-tier biosynthetics. Japan’s mature payer system supports robotic adoption, while Australia and South Korea champion outpatient pathways. International OEMs increasingly partner with regional distributors to navigate varying regulatory timelines and local tender processes.

Competitive Landscape
The hernia repair devices and procedures market features a core of diversified multinationals plus a cohort of focused innovators. BD, after settling the bulk of mesh lawsuits for USD 1 billion, is channelling capital toward fully absorbable platforms and antimicrobial designs. Medtronic is integrating its mesh portfolio with the Hugo RAS robot, targeting seamless instrument-mesh workflows that can lift procedure throughput. Johnson & Johnson’s Ethicon unit remains a volume leader, but the company is refreshing its lineup with energy devices compatible across open, laparoscopic and robotic modalities.
Specialists add competitive friction. TELA Bio grew revenue 26% in Q3 2024 by positioning biologic-reinforced OviTex as a cost-effective alternative to porcine dermis while securing CE-mark for robotic delivery. W. L. Gore leans on ePTFE and biosynthetic R&D to anchor premium ASPs. New entrants such as Absolutions are pursuing breakthrough status for novel closure systems that could slash operating time and seroma rates. Across the board, vendors that bundle mesh, fixation, robotics and analytics into end-to-end solutions are gaining favour with large hospital systems aiming to standardise supplies.
Hernia Repair Devices And Procedures Industry Leaders
-
Medtronic Plc
-
Johnson & Johnson (Ethicon)
-
Becton, Dickinson and Company
-
B. Braun SE
- *Disclaimer: Major Players sorted in no particular order

Recent Industry Developments
- December 2022: Deep Blue Medical Advances received an additional 510(k) clearance from the United States FDA for its T-Line Hernia Mesh for the sublay technique in open hernia surgery.
- October 2022: TELA Bio published 24-month BRAVO study results demonstrating the benefits of OviTex reinforced tissue matrix in hernia repair.
Global Hernia Repair Devices And Procedures Market Report Scope
As per the scope of the report, a hernia is a medical condition where an organ or fatty tissue bulges out through a weak spot where they are normally contained. Hernia repair is a surgical operation for the treatment of a hernia. The devices and accessories used for the operation are in the scope of the report. The report provides a detailed analysis of the hernia repair devices market. The Hernia Repair devices market is Segmented by Product (Polymeric and Prosthetic Mesh, Endoscopy Instruments, Surgical Instruments, Biologic Materials, and Other Products), Procedure (Open Tension Repair, Tension-free Repair, Laparoscopic Surgery, and Other Procedures), and Geography (North America, Europe, Asia-pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends of 17 countries across major regions, globally. The report offers (in USD million) values for the above segments.
By Product | Synthetic Polypropylene Mesh | ||
Expanded-PTFE Mesh | |||
Light-Weight Large-Pore Mesh | |||
Biologic/Biosynthetic Mesh | |||
Surgical & Endoscopic Instruments | |||
Fixation Devices (Tackers, Sutures, Glues) | |||
By Procedure | Open Tension Repair | ||
Open Tension-Free (Lichtenstein) Repair | |||
Laparoscopic Intraperitoneal-Onlay Mesh (IPOM) | |||
Robotic-Assisted Laparoscopic Repair | |||
By Hernia Type | Inguinal Hernia | ||
Incisional/Ventral Hernia | |||
Umbilical Hernia | |||
Femoral & Other Hernias | |||
By Material | Synthetic | ||
Biologic | |||
Hybrid Biosynthetic | |||
By End User | Hospitals | ||
Ambulatory Surgical Centres (ASCs) | |||
Specialty Hernia Clinics | |||
Geography | North America | United States | |
Canada | |||
Mexico | |||
Europe | Germany | ||
United Kingdom | |||
France | |||
Italy | |||
Spain | |||
Rest of Europe | |||
Asia-Pacific | China | ||
Japan | |||
India | |||
Australia | |||
South Korea | |||
Rest of Asia-Pacific | |||
Middle East & Africa | GCC | ||
South Africa | |||
Rest of Middle East & Africa | |||
South America | Brazil | ||
Argentina | |||
Rest of South America |
Synthetic Polypropylene Mesh |
Expanded-PTFE Mesh |
Light-Weight Large-Pore Mesh |
Biologic/Biosynthetic Mesh |
Surgical & Endoscopic Instruments |
Fixation Devices (Tackers, Sutures, Glues) |
Open Tension Repair |
Open Tension-Free (Lichtenstein) Repair |
Laparoscopic Intraperitoneal-Onlay Mesh (IPOM) |
Robotic-Assisted Laparoscopic Repair |
Inguinal Hernia |
Incisional/Ventral Hernia |
Umbilical Hernia |
Femoral & Other Hernias |
Synthetic |
Biologic |
Hybrid Biosynthetic |
Hospitals |
Ambulatory Surgical Centres (ASCs) |
Specialty Hernia Clinics |
North America | United States |
Canada | |
Mexico | |
Europe | Germany |
United Kingdom | |
France | |
Italy | |
Spain | |
Rest of Europe | |
Asia-Pacific | China |
Japan | |
India | |
Australia | |
South Korea | |
Rest of Asia-Pacific | |
Middle East & Africa | GCC |
South Africa | |
Rest of Middle East & Africa | |
South America | Brazil |
Argentina | |
Rest of South America |
Key Questions Answered in the Report
What is the current size of the hernia repair devices and procedures market?
The market is valued at USD 6.77 billion in 2025 and is forecast to reach USD 8.37 billion by 2030.
Which product type leads the market?
Synthetic polypropylene mesh holds the top spot with a 48.43% revenue share as of 2024.
How fast are robotic hernia repairs growing?
Robotic-assisted laparoscopic repairs are expanding at a 6.66% CAGR through 2030, the quickest pace among procedure types.
Why are ambulatory surgery centers gaining share?
Medicare payment increases, same-day discharge protocols and lower facility fees are driving ASC volumes, supporting a 7.86% CAGR.
Which region is the fastest growing?
Asia-Pacific is advancing at a 5.67% CAGR thanks to infrastructure investment and rising surgical capacity in China, India and Japan.
What impact did BD’s litigation settlement have on the market?
The USD 1 billion settlement resolved most mesh lawsuits, reducing regulatory uncertainty and allowing BD and peers to refocus on product innovation.
Page last updated on: June 24, 2025